Associate Professor, Medicine, University of California San Diego School of Medicine
Allergy & Immunology
Dr. Anthony A. Horner, MD
|
|
Give Review
Dr. Anthony A. Horner is an expert in the field of Allergy & Immunology. He researched medicine at Saint Louis University School of Medicine. Saint Louis University School of Medicine is ranked 67/57 in Research/PrimaryCare. He received awards:"Fellow (FAAAAI)". Anthony A. Horner, MD is a published doctor and has 44 publications published. The lastest was: 'Immunostimulatory DNA is a potent mucosal adjuvant.'
Publications
- House dust bioactivities predict skin prick test reactivity for children with high risk of allergy.
- Invariant NKT cells are required for airway inflammation induced by environmental antigens.
- Regulatory T cells contribute to allergen tolerance induced by daily airway immunostimulant exposures.
- Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity.
- Allergen tolerance versus the Allergic march: the hygiene hypothesis revisited.
- Airway house dust extract exposures modify allergen-induced airway hypersensitivity responses by TLR4-dependent and independent pathways.
- Update on toll-like receptor ligands and allergy: implications for immunotherapy.
- House dust extracts have both TH2 adjuvant and tolerogenic activities.
- Toll-like receptor ligands and atopy: a coin with at least two sides.
- House dust extracts elicit Toll-like receptor-dependent dendritic cell responses.
- Toll-like receptor ligands: hygiene, atopy and therapeutic implications.
- Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
- Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.
- Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy.
- Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of Allergic diseases.
- Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity.
- CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1).
- Chondrocyte-peripheral blood mononuclear cell interactions: the role of ICAM-1.
- Detection of cytokine activated chondrocytes in arthritic joints from pigs infected with Erysipelothrix rhusiopathiae.
- Fibroblast growth factor signaling regulates Dach1 expression during skeletal development.
- Allergen-independent immunomodulatory activities of immunoglobulin E.
- DNA-based vaccination for the treatment of food allergy.
- gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes.
- The prevalence of environmental exposure to perceived asthma triggers in children with mild-to-moderate asthma: data from the Childhood Asthma Management Program (CAMP).
- Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant.
- Immunostimulatory DNA-based therapeutics for experimental and clinical allergy.
- Pre-priming: a novel approach to DNA-based vaccination and immunomodulation.
- Immunostimulatory DNA is a potent mucosal adjuvant.
- Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells.
- Immunostimulatory-sequence DNA is an effective mucosal adjuvant.
- DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice.
- IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.
- Mucosal adjuvanticity of immunostimulatory DNA sequences.
- DNA-based immunotherapeutics for the treatment of Allergic disease.
- Immunostimulatory DNA pre-priming: a novel approach for prolonged Th1-biased immunity.
- Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.
- Do microbes influence the pathogenesis of Allergic diseases? Building the case for Toll-like receptor ligands.
- Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental Allergic rhinitis.
- Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications.
- Defining a role for ambient TLR ligand exposures in the genesis and prevention of Allergic diseases.
- Update on toll-like receptor-directed therapies for human disease.
- Using house dust extracts to understand the immunostimulatory activities of living environments.
- Regulation of aeroallergen immunity by the innate immune system: laboratory evidence for a new paradigm.
Schools
Saint Louis University School of Medicine
University Of California Los Angeles
Boston Chldn39S Hospital
Procedures Preformed
- Allergy Skin Testing
Conditions Treated
- Allergic Rhinitis
- Pinkeye (Conjunctivitis)
Doctors Specialties
- Pediatrics
- Allergy
- Immunology
Accepted Insurances
Awards
- Fellow (FAAAAI)
Education
-
Boston Children's Hospital -
UCLA Medical Center -
Saint Louis University School of Medicine
Hospital
-
UC San Diego Health -
Rady Children's Hospital - San Diego
Helpful Reviews
Similar Doctors
|
|
Dr. Frank Q. Tang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Y. Ing, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven R. Griffin Jr., MD |
|
|
Dr. Seema S. Aceves, MD |
|
|
Dr. Natasha A. Rodgers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kishore K. Vasant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard D. Cragen, MD |
|
|
Dr. Asif A. Imam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ehab S. Nashed, MD |
|
Dr. Shams Iqbal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dale B. Sparks, MD
This Doctor is OpenDoctor Recommended.
|